Island Pharmaceuticals starts Galidesivir production for Ebola emergency-use program

The company says PI Health Sciences started GMP production of the drug’s active pharmaceutical ingredient on October 1, with the first 5-kilogram batch targeted for completion by…

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.themercury.com.au)